Universitätsmedizin Berlin, the research network involves all 36 German university hospitals and partners on working on solutions for the best possible health care and pandemic preparedness. Emphasis is
biomaterial and their derivatives (DNA, RNA, meta data, cell lines) for DZIF and other partners at the DZIF partner sites Setup of a method platform for the generation of derivatives and improved analysis [...] meta data of the samples becomes available for the DZIF partners Development of structured ELSI, QM und IT solutions for DZIF biobanks and partners https://www.dzif.de/en/infrastructure/biobanking GBA German [...] locations and to transfer the research results into practice. Biospecimen of high pertinence for DZIF partners are for example cultures of pathogens and so-called microbial producers, which are bacteria that
professional services to academic researchers in case of MHH trial sponsorship and also to industry partners and can draw on many years of professional experience. Founded in 2005, the Hannover Clinical Trial
by Professor Hartmann from Neuropathology and Professor Krauss from Neurosurgery, as well as with partners from the University Medical Center Göttingen (UMG), are now demonstrating a new mechanism that improves
23rd, 2007. In this building, which is to be finished in summer 2008, those scientists and further partner institutes will be accommodated, who last year for the project REBIRTH ("From regenerative Biology
as 'Research Center for Translational Regenerative Medicine'. In addition to the MHH, seven other partners are involved: the Leibniz Universität Hannover, the Laser Zentrum Hannover e.V., the Stiftung T
Hannover, Würzburg, Heidelberg, Göttingen and Munich are co-coordinators. Additional implementation partners are Berlin, Dresden, Essen, Freiburg, Mainz, Münster, Ulm, and Cottbus.
including rejection reactions. In addition, our scientific interest in cooperation with clinical partners of the MHH and other university hospitals also applies to immunosuppression after organ transplantation
Region Hannover" (Hanover Region Researchers' Kids Network), the Hanover Region is a cooperation partner of the foundation, organizes the training courses, finances the personnel and material costs and
to disturbed communications between immune cells and endothelium. Therefore, together with DZIF partners in Munich (TUM, LMU), Heidelberg, Marburg, Tübingen and Hamburg (UKE), we are investigating important